Skip to main content
. Author manuscript; available in PMC: 2021 Aug 18.
Published in final edited form as: J Neurol Neurosurg Psychiatry. 2020 Aug 7;91(9):975–984. doi: 10.1136/jnnp-2020-322987

Table 2. CBI total and sub-scale scores at baseline and over time for at-risk family members by genetic group (no outliers included).

Baseline# Change Score
N Estimate (95% CI) p-value N Estimate (95% CI) p-value
Total Score 588 336
C9orf72 104 1.34 (0.78, 2.31) 0.29 0.28 (−1.42, 1.97) 0.75
GRN 138 0.95 (0.52, 1.73) 0.86 0.38 (−0.8, 1.56) 0.53
MAPT 52 1.96 (0.88, 4.38) 0.1 0.39 (−1.37, 2.15) 0.66
YEO 1.02 (1, 1.03) 0.02 0.03 (−0.01, 0.07) 0.11
Baseline score - - −0.15 (−0.21, −0.1) <.0001
C9orf72*YEO 1 (0.98, 1.03) 0.8 0.01 (−0.08, 0.11) 0.78
GRN*YEO 1 (0.97, 1.03) 0.87 −0.02 (−0.08, 0.05) 0.63
MAPT*YEO 1 (0.96, 1.05) 0.85 −0.01 (−0.12, 0.1) 0.86
Memory and Orientation 588 334
C9orf72 104 0.88 (0.51, 1.52) 0.65 49 −0.02 (−0.41, 0.37) 0.92
GRN 138 1.03 (0.56, 1.89) 0.92 85 −0.03 (−0.3, 0.25) 0.85
MAPT 52 0.89 (0.39, 2.03) 0.78 33 −0.01 (−0.42, 0.41) 0.98
YEO 1.03 (1.01, 1.04) 0.001 0.01 (0.002, 0.02) 0.02
Baseline score - - −0.18 (−0.23, −0.13) <.0001
C9orf72*YEO 0.98 (0.96, 1.01) 0.29 −0.003 (−0.02, 0.02) 0.74
GRN*YEO 1.01 (0.98, 1.04) 0.47 −0.002 (−0.02, 0.01) 0.78
MAPT*YEO 0.99 (0.95, 1.03) 0.59 0.0003 (−0.02, 0.03) 0.98
Everyday Skills 588 335
C9orf72 104 0.77 (0.09, 6.56) 0.81 50 0.07 (−0.01, 0.14) 0.09
GRN 138 0.71 (0.1, 4.92) 0.72 85 0.11 (0.05, 0.16) 0.0001
MAPT 52 1.08 (0.05, 22.27) 0.96 32 0.03 (−0.06, 0.11) 0.53
YEO 1.03 (0.97, 1.09) 0.34 0.001 (0, 0) 0.57
Baseline score - - −0.5 (−0.55, −0.45) <.0001
C9orf72*YEO 1 (0.89, 1.13) 0.96 0.003 (0, 0.01) 0.21
GRN*YEO 1.05 (0.93, 1.2) 0.42 0.003 (0, 0.01) 0.07
MAPT*YEO 0.96 (0.82, 1.11) 0.57 0.0002 (0, 0.01) 0.95
Abnormal Behaviour 588 334
C9orf72 104 2.16 (1.09, 4.26) 0.03 48 −0.02 (−0.3, 0.25) 0.86
GRN 138 0.83 (0.36, 1.91) 0.67 86 −0.03 (−0.22, 0.15) 0.73
MAPT 52 2.07 (0.8, 5.38) 0.14 33 −0.02 (−0.3, 0.26) 0.89
YEO 1 (0.98, 1.02) 0.9 0.004 (0, 0.01) 0.19
Baseline score - - −0.23 (−0.28, −0.18) <.0001
C9orf72*YEO 1.02 (0.98, 1.06) 0.37 −0.006 (−0.02, 0.01) 0.47
GRN*YEO 1 (0.96, 1.04) 0.99 −0.007 (−0.02, 0) 0.23
MAPT*YEO 0.99 (0.95, 1.04) 0.77 −0.0033 (−0.02, 0.01) 0.71
Mood 587 334
C9orf72 104 1.22 (0.7, 2.12) 0.49 49 −0.07 (−0.47, 0.34) 0.75
GRN 137 0.46 (0.23, 0.93) 0.03 84 0.18 (−0.11, 0.47) 0.2
MAPT 52 2.75 (1.29, 5.89) 0.01 33 0.38 (−0.05, 0.81) 0.08
YEO 1.01 (0.99, 1.03) 0.26 −0.002 (−0.01, 0.01) 0.7
Baseline score - - −0.23 (−0.28, −0.18) <.0001
C9orf72*YEO 1 (0.97, 1.03) 0.80 −0.018 (−0.04, 0) 0.11
GRN*YEO 0.97 (0.94, 1) 0.05 −0.003 (−0.02, 0.01) 0.73
MAPT*YEO 1.01 (0.97, 1.05) 0.58 0.0031 (−0.02, 0.03) 0.81
Beliefs 340
C9orf72 49 −0.004 (−0.02, 0.01) 0.56
GRN 86 −0.01 (−0.02, 0.0014) 0.097
MAPT 33 −0.01 (−0.02, 0.01) 0.46
YEO 0.00007 (−0.0002, 0.0004) 0.62
Baseline score −0.38 (−0.41, −0.34) <.0001
C9orf72*YEO −0.00017 (−0.0009, 0.0005) 0.64
GRN*YEO −0.00017 (−0.0007, 0.0004) 0.52
MAPT*YEO −0.0001 (−0.0009, 0.0007) 0.86
Eating habits 588 335
C9orf72 104 0.61 (0.16, 2.32) 0.46 49 −0.02 (−0.2, 0.16) 0.83
GRN 138 1.57 (0.46, 5.39) 0.47 86 0 (−0.13, 0.1247) 0.99
MAPT 52 0.68 (0.1, 4.82) 0.70 32 0.1 (−0.09, 0.29) 0.29
YEO 1.05 (1.01, 1.09) 0.01 0.0041 (0.0001, 0.008) 0.04
Baseline score - - −0.35 (−0.39, −0.31) <.0001
C9orf72*YEO 0.96 (0.89, 1.03) 0.25 −0.006 (−0.02, 0.005) 0.28
GRN*YEO 1 (0.94, 1.07) 0.91 −0.00002 (−0.007, 0.007) 0.996
MAPT*YEO 0.95 (0.87, 1.05) 0.35 0.003 (−0.008, 0.01) 0.6
Sleep 588 334
C9orf72 104 1.4 (0.75, 2.64) 0.29 49 −0.13 (−0.39, 0.13) 0.33
GRN 138 1.16 (0.56, 2.39) 0.68 86 0.05 (−0.14, 0.23) 0.62
MAPT 52 3.37 (1.46, 7.74) 0.004 32 0.02 (−0.26, 0.3) 0.89
YEO 1.03 (1.01, 1.05) 0.01 −0.0009 (−0.007, 0.005) 0.76
Baseline score - - −0.28 (−0.33, −0.22) <.0001
C9orf72*YEO 1.01 (0.97, 1.05) 0.56 −0.008 (−0.02, 0.006) 0.25
GRN*YEO 1 (0.96, 1.04) 0.86 0.003 (−0.008, 0.01) 0.63
MAPT*YEO 1.03 (0.98, 1.08) 0.26 −0.005 (−0.02, 0.01) 0.54
Stereotypic and motor behaviours 588 335
C9orf72 104 2.15 (1.05, 4.39) 0.04& 49 −0.12 (−0.42, 0.18) 0.44
GRN 138 1.07 (0.46, 2.52) 0.87 86 0.08 (−0.13, 0.28) 0.47
MAPT 52 1 (0.31, 3.23) 0.999 32 0.002 (−0.31, 0.32) 0.99
YEO 1.02 (1, 1.05) 0.05 0.0079 (0.001, 0.01) 0.02
Baseline score - - −0.3 (−0.37, −0.24) <.0001
C9orf72*YEO 1.03 (0.98, 1.07) 0.23 −0.01 (−0.03, 0.007) 0.23
GRN*YEO 1 (0.96, 1.05) 0.96 0.0001 (−0.01, 0.01) 0.99
MAPT*YEO 0.94 (0.89, 1) 0.05 0.002 (−0.02, 0.02) 0.86
Motivation 587 330
C9orf72 104 1.91 (0.72, 5.06) 0.19 49 0.093 (−0.19, 0.38) 0.52
GRN 138 0.93 (0.31, 2.75) 0.9 84 0.02 (−0.19, 0.22) 0.88
MAPT 52 3.68 (1, 13.52) 0.05& 31 0.0004 (−0.3, 0.3) 1
YEO 1.05 (1.02, 1.08) 0.003 0.002 (−0.0047, 0.008) 0.62
Baseline score - - −0.26 (−0.33, −0.19) <.0001
C9orf72*YEO 0.98 (0.93, 1.04) 0.51 0.005 (−0.0109, 0.02) 0.54
GRN*YEO 0.97 (0.92, 1.02) 0.26 0.006 (−0.0057, 0.02) 0.31
MAPT*YEO 0.97 (0.9, 1.04) 0.41 −0.006 (−0.0247, 0.01) 0.49

Statistics are from the Solution for Fixed Effects Table

#

Baseline data was modeled with a negative binomial distribution with a log link function. Estimates and confidence intervals of fixed effects are exponentiated (base e) and indicate the incident rates. Estimates below 1 indicate an inverse relationship between the variable and outcome

&

Overall effect of genetic group was not statistically significant at p<0.05 (based on Type III Tests of Fixed Effects)

The model could not be run on some subscales after outliers were removed due to low symptom endorsement. At baseline, for the self-care sub-scale, 3 participants (3 preclinical) had scores above zero after outliers were removed. At baseline, for the beliefs sub-scale, 4 participants (1 preclinical, 2 non-carrier) had scores above zero after outliers were removed. For the change score, for the self-care scale, 1 non-carrier endorsed a change in symptom.

For the main effect of genetic group and Gene*EYO interaction= reference group are the non-carriers

YEO= Years from estimated onset; CI=confidence interval